Traub W H, Leonhard B, Bauer D
Institut für Medizinische Mikrobiologie und Hygiene, Universität des Saarlandes, Homburg/Saar, Germany.
Chemotherapy. 1996 Jan-Feb;42(1):21-36. doi: 10.1159/000239419.
Nineteen representative isolates of gentamicin- and methicillin-resistant Staphylococcus aureus (MRSA) were found to comprise three phenotypes; these differed with regard to hydrolysis of nitrocefin and production of staphylococcal enterotoxin A or/and toxic shock syndrome toxin-1. All MRSA isolates produced a capsule and were susceptible to coumermycin, nitrofurantoin, novobiocin, trimethoprim, trimethoprim-sulfamethoxazole, teicoplanin and vancomycin. All MRSA isolates were resistant to co-amoxiclav, ciprofloxacin, clarithromycin, gentamicin, methicillin, norfloxacin, ofloxacin, oxacillin and polymyxin B.
19株庆大霉素和甲氧西林耐药金黄色葡萄球菌(MRSA)的代表性菌株被发现包含三种表型;这些表型在头孢硝噻吩水解以及葡萄球菌肠毒素A或/和中毒性休克综合征毒素-1的产生方面存在差异。所有MRSA菌株均产生荚膜,且对香豆霉素、呋喃妥因、新生霉素、甲氧苄啶、甲氧苄啶-磺胺甲恶唑、替考拉宁和万古霉素敏感。所有MRSA菌株对阿莫西林克拉维酸、环丙沙星、克拉霉素、庆大霉素、甲氧西林、诺氟沙星、氧氟沙星、苯唑西林和多粘菌素B耐药。